Senior Machine Learning Engineer, Genesis Therapeutics

Infra

Salary not provided

+ Equity

Kubernetes
Terraform
CUDA
PyTorch
Senior level
Remote in US
San Francisco Bay Area
Genesis Therapeutics

Unifying AI and biotechnology for drug discovery

Open for applications

Genesis Therapeutics

Unifying AI and biotechnology for drug discovery

21-100 employees

HealthcareB2BArtificial IntelligenceDeep TechBiologyMachine LearningScienceMedTech

Open for applications

Salary not provided

+ Equity

Kubernetes
Terraform
CUDA
PyTorch
Senior level
Remote in US
San Francisco Bay Area

21-100 employees

HealthcareB2BArtificial IntelligenceDeep TechBiologyMachine LearningScienceMedTech

Company mission

To transform small molecule drug discovery to solve critical patient needs.

Company mission

To transform small molecule drug discovery to solve critical patient needs.

Top investors

Few candidates hear
back within 2 weeks

Otta's take

Sam Franklin headshot

Sam Franklin

CEO of Otta

Genesis Therapeutics is at the forefront of advancing drug creation to foster better healthcare outcomes. the company offers an AI-powered molecule discovery platform, known as GEMS, designed to empower medical researchers. By seamlessly integrating AI with biotech, GEMS leverages deep learning and molecular simulations to explore uncharted territories within chemical space, unveiling novel opportunities for functional drugs.

Boasted to be the "industry's most advanced molecular AI platform", GEMS accelerates the discovery of small molecules while also enhancing potency and selectivity. This breakthrough capability not only expedites the development process but also paves the way for creating medications targeting previously inaccessible domains.

With significant funding backing its endeavours, Genesis Therapeutics is poised to transition into clinical testing. Moreover, the company aims to broaden the scope of its platform, extending its reach to encompass a wider array of therapeutic targets.

Benefits

  • 401(k) Plan
  • Stock Option Eligibility
  • Open PTO Policy
  • Paid Company Holidays
  • Free lunch and snacks at our offices
  • Health Care Plan, including Medical, Dental, and Vision, fully covered for the employees

Funding (last 2 of 3 rounds)

Aug 2023

$224.1m

SERIES B

Dec 2020

$52m

SERIES A

Total funding: $280.2m

This company has top investors

Founders

PhD Graduate from Stanford, where they were an Algorithm Developer, collaborating with the Office of Technology Licensing to develop BraneRank (which uses graph substructures to rank search results). Was then a Deep Learning Consultant for Merck for 11 months.

Graduated from UC Berkeley with a degree in Electrical Engineering and Computer Science. Worked at Markforged for 3 years, ultimately as Director of Software Engineering.

Jobs (4)

All locations

Software Engineering